John S. Yordy

2.6k total citations
32 papers, 1.5k citations indexed

About

John S. Yordy is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John S. Yordy has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John S. Yordy's work include Advanced Radiotherapy Techniques (5 papers), Head and Neck Cancer Studies (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). John S. Yordy is often cited by papers focused on Advanced Radiotherapy Techniques (5 papers), Head and Neck Cancer Studies (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). John S. Yordy collaborates with scholars based in United States, China and Russia. John S. Yordy's co-authors include Robin C. Muise‐Helmericks, Uma Giri, Dennis K. Watson, Stephen G. Chun, Runzhao Li, Huiping Pei, Heath D. Skinner, Thomas J. Ow, Alison L. Fitzgerald and Jeffrey N. Myers and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

John S. Yordy

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Yordy United States 18 788 605 353 346 135 32 1.5k
Cordula Petersen Germany 26 1.0k 1.3× 870 1.4× 493 1.4× 435 1.3× 212 1.6× 60 2.0k
Chao‐Nan Qian China 20 932 1.2× 380 0.6× 476 1.3× 447 1.3× 84 0.6× 49 1.5k
Mohamed E. Abazeed United States 20 565 0.7× 355 0.6× 449 1.3× 474 1.4× 354 2.6× 67 1.6k
Jean–Louis Fischel France 24 817 1.0× 1.2k 2.0× 348 1.0× 599 1.7× 149 1.1× 62 1.9k
Khaled A. Hassan United States 23 1.3k 1.7× 1.2k 1.9× 519 1.5× 482 1.4× 231 1.7× 49 2.5k
F. Ettore France 21 553 0.7× 737 1.2× 803 2.3× 294 0.8× 324 2.4× 77 1.7k
Andreas Schnelzer Germany 13 525 0.7× 338 0.6× 185 0.5× 97 0.3× 94 0.7× 28 1.1k
Olga Goloubeva United States 16 755 1.0× 502 0.8× 186 0.5× 239 0.7× 78 0.6× 27 1.3k
Leslie A. Parsels United States 24 1.5k 1.9× 1.4k 2.3× 349 1.0× 289 0.8× 67 0.5× 39 2.1k
Kenneth F. Grossmann United States 27 997 1.3× 1.2k 2.1× 273 0.8× 517 1.5× 79 0.6× 95 2.3k

Countries citing papers authored by John S. Yordy

Since Specialization
Citations

This map shows the geographic impact of John S. Yordy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Yordy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Yordy more than expected).

Fields of papers citing papers by John S. Yordy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Yordy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Yordy. The network helps show where John S. Yordy may publish in the future.

Co-authorship network of co-authors of John S. Yordy

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Yordy. A scholar is included among the top collaborators of John S. Yordy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Yordy. John S. Yordy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Lianghao, Brock J. Sishc, John S. Yordy, et al.. (2022). Evaluation of the Response of HNSCC Cell Lines to γ-Rays and 12C Ions: Can Radioresistant Tumors Be Identified and Selected for 12C Ion Radiotherapy?. Frontiers in Oncology. 12. 812961–812961. 7 indexed citations
2.
Vo, Dat T., Narasimha Kumar Karanam, Lianghao Ding, et al.. (2019). miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer. Neoplasia. 21(9). 849–862. 43 indexed citations
3.
Ding, Chuxiong, Stephen G. Chun, Baran D. Sumer, et al.. (2017). Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer. Medical dosimetry. 42(2). 90–96. 5 indexed citations
4.
Li, Long-Shan, Shuangping Liu, Hyunsil Park, et al.. (2016). NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer. Molecular Cancer Therapeutics. 15(7). 1757–1767. 45 indexed citations
5.
Chun, Stephen G., Hyunsil Park, Raj K. Pandita, et al.. (2015). Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers. Europe PMC (PubMed Central). 3 indexed citations
6.
Meng, Tao, Shu‐Ching Chen, S. S. Iyengar, et al.. (2015). Driver Missense Mutation Identification Using Feature Selection and Model Fusion. Journal of Computational Biology. 22(12). 1075–1085. 1 indexed citations
7.
Chun, Stephen G., Hyunsil Park, Raj K. Pandita, et al.. (2015). Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.. PubMed. 5(4). 1337–52. 11 indexed citations
8.
Cao, Lifen, Long Shan Li, Ling Xiao, et al.. (2014). Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers. Antioxidants and Redox Signaling. 21(2). 237–250. 32 indexed citations
9.
Chun, Stephen G., Lucien Nedzi, Kevin S. Choe, et al.. (2014). A Retrospective Analysis of Tumor Volumetric Responses to Five-Fraction Stereotactic Radiotherapy for Paragangliomas of the Head and Neck (Glomus Tumors). Stereotactic and Functional Neurosurgery. 92(3). 153–159. 14 indexed citations
10.
Kearney, Vasant, Xuejun Gu, Tsuicheng Chiu, et al.. (2014). Automated landmark-guided deformable image registration. Physics in Medicine and Biology. 60(1). 101–116. 19 indexed citations
11.
Meng, Tao, Mei‐Ling Shyu, Yimin Yang, et al.. (2013). Wavelet Analysis in Current Cancer Genome Research: A Survey. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 10(6). 1442–14359. 31 indexed citations
12.
Gupta, Arun, Clayton R. Hunt, Sharmistha Chakraborty, et al.. (2013). Role of 53BP1 in the Regulation of DNA Double-Strand Break Repair Pathway Choice. Radiation Research. 181(1). 1–8. 116 indexed citations
13.
Chun, Stephen G., Kevin S. Choe, Puneeth Iyengar, John S. Yordy, & Robert Timmerman. (2012). Isolated central nervous system progression on Crizotinib. Cancer Biology & Therapy. 13(14). 1376–1383. 87 indexed citations
14.
Moeller, Benjamin J., John S. Yordy, Michelle D. Williams, et al.. (2011). DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy. Clinical Cancer Research. 17(7). 2035–2043. 75 indexed citations
15.
Skinner, Heath D., Vlad C. Sandulache, Thomas J. Ow, et al.. (2011). TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence. Clinical Cancer Research. 18(1). 290–300. 222 indexed citations
16.
Yordy, John S., Peter R. Almond, & Luis Delclos. (2011). Development of the M. D. Anderson Cancer Center Gynecologic Applicators for the Treatment of Cervical Cancer: Historical Analysis. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1445–1453. 1 indexed citations
17.
18.
Findlay, Victoria J., David P. Turner, John S. Yordy, et al.. (2011). Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. Genes & Cancer. 2(2). 120–129. 18 indexed citations
19.
Crane, Christopher H., John S. Yordy, Gauri R. Varadhachary, et al.. (2011). Use of DPC-4 immunostaining of diagnostic cytology specimens to predict the pattern of tumor progression in locally advanced pancreatic cancer patients (LAPC).. Journal of Clinical Oncology. 29(4_suppl). 209–209. 1 indexed citations
20.
Yordy, John S., Omar Moussa, Huiping Pei, et al.. (2004). SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene. 24(5). 916–931. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cordula Petersen Breakdown of academic impact, for papers by Chao‐Nan Qian Breakdown of academic impact, for papers by Mohamed E. Abazeed Breakdown of academic impact, for papers by Jean–Louis Fischel Breakdown of academic impact, for papers by Khaled A. Hassan Breakdown of academic impact, for papers by F. Ettore Breakdown of academic impact, for papers by Andreas Schnelzer Breakdown of academic impact, for papers by Olga Goloubeva Breakdown of academic impact, for papers by Leslie A. Parsels Breakdown of academic impact, for papers by Kenneth F. Grossmann
Rankless by CCL
2026